Register Login

GYRE THERAPEUTICS, INC. (GYRE)

Eastling Thomas Wilson 🟢 acquired 408.8K shares (7 derivative) of GYRE THERAPEUTICS, INC. (GYRE) at $5.98 Transaction Date: May 04, 2026 | Filing ID: 019376

Full text
Register to leave comments
  • News bot May 7, 2026, 12:38 a.m.

    🔍 Eastling Thomas Wilson (Executive)

    Company: GYRE THERAPEUTICS, INC. (GYRE)

    Report Date: 2026-05-04

    Transaction Summary:

    • Total transactions: 7
    • Derivative instruments: 7
    • Holdings reported: 0
    • Total shares acquired: 408,757

    Detailed Transactions and Holdings:

    • Acquired 95,060 shares of Stock Option (Right to Buy) at $0.32 per share (Derivative)
      Date: 2026-05-04 | Code: A | Expires: 2028-06-07 | equity_swap_involved: 0 | shares_owned_after: 95,060.00 | transaction_form_type: 4 | Footnotes: F1
    • Acquired 47,530 shares of Stock Option (Right to Buy) at $0.93 per share (Derivative)
      Date: 2026-05-04 | Code: A | Expires: 2030-01-12 | equity_swap_involved: 0 | shares_owned_after: 47,530.00 | transaction_form_type: 4 | Footnotes: F1
    • Acquired 11,882 shares of Stock Option (Right to Buy) at $2.0 per share (Derivative)
      Date: 2026-05-04 | Code: A | Expires: 2030-12-17 | equity_swap_involved: 0 | shares_owned_after: 11,882.00 | transaction_form_type: 4 | Footnotes: F1
    • Acquired 33,271 shares of Stock Option (Right to Buy) at $2.0 per share (Derivative)
      Date: 2026-05-04 | Code: A | Expires: 2031-06-09 | equity_swap_involved: 0 | shares_owned_after: 33,271.00 | transaction_form_type: 4 | Footnotes: F1
    • Acquired 95,060 shares of Stock Option (Right to Buy) at $2.34 per share (Derivative)
      Date: 2026-05-04 | Code: A | Expires: 2032-01-23 | equity_swap_involved: 0 | shares_owned_after: 95,060.00 | transaction_form_type: 4 | Footnotes: F1
    • Acquired 92,683 shares of Stock Option (Right to Buy) at $5.98 per share (Derivative)
      Date: 2026-05-04 | Code: A | Expires: 2034-11-12 | equity_swap_involved: 0 | shares_owned_after: 92,683.00 | transaction_form_type: 4 | Footnotes: F2
    • Acquired 33,271 shares of Stock Option (Right to Buy) at $0.32 per share (Derivative)
      Date: 2026-05-04 | Code: A | Expires: 2028-06-07 | equity_swap_involved: 0 | shares_owned_after: 33,271.00 | transaction_form_type: 4 | Footnotes: F1

    Footnotes:

    • F1: This option is fully vested.
    • F2: This option represents a right to purchase 92,683 shares of the Issuer's common stock, one quarter of which vested on November 13, 2025, with the remaining three quarters vesting in equal monthly installments over the following three years, subject to the Reporting Person's continued service to the Issuer on each such vesting date.
    • REMARKS: Exhibit 24 - Power of Attorney

Search

News categories